-transparent.png){kind=logo}
Tumor necrosis factor (TNF) is a pleiotropic mediator of inflammation that has been implicated in the pathogenesis of devastating clinical syndromes including septic shock. We have investigated the role of a TNF-responsive phosphatidylcholine-specific phospholipase C (PC-PLC) for the cytotoxic and proinflammatory activity of TNF. We show here that the cytotoxicity signaled for by the so-called "death domain" of the p55 TNF receptor is associated with the activation of PC-PLC. The xanthogenate tricyclodecan-9-yl (D609), a specific and selective inhibitor of PC-PLC, blocked the cytotoxic action of TNF on L929 and Wehi164 cells. In vivo, D609 prevented both adhesion molecule expression in the pulmonary vasculature and the accompanying leukocyte infiltration in TNF-treated mice. More strikingly, D609 protects BALB/c mice from lethal shock induced either by TNF, lipopolysaccharide, or staphylococcal enterotoxin B. Together these findings imply PC-PLC as an important mediator of the pathogenic action of TNF, suggesting that PC-PLC may serve as a novel target for anti-inflammatory TNF antagonists.
T Machleidt, and
B Krämer, and
D Adam, and
B Neumann, and
S Schütze, and
K Wiegmann, and
M Krönke
April 1999,
The Journal of biological chemistry,
T Machleidt, and
B Krämer, and
D Adam, and
B Neumann, and
S Schütze, and
K Wiegmann, and
M Krönke
November 1991,
The Journal of experimental medicine,
T Machleidt, and
B Krämer, and
D Adam, and
B Neumann, and
S Schütze, and
K Wiegmann, and
M Krönke
December 2000,
The Journal of biological chemistry,
T Machleidt, and
B Krämer, and
D Adam, and
B Neumann, and
S Schütze, and
K Wiegmann, and
M Krönke
April 2005,
Biochemical and biophysical research communications,
T Machleidt, and
B Krämer, and
D Adam, and
B Neumann, and
S Schütze, and
K Wiegmann, and
M Krönke
November 2001,
Protein expression and purification,
T Machleidt, and
B Krämer, and
D Adam, and
B Neumann, and
S Schütze, and
K Wiegmann, and
M Krönke
September 1997,
The Journal of clinical investigation,
T Machleidt, and
B Krämer, and
D Adam, and
B Neumann, and
S Schütze, and
K Wiegmann, and
M Krönke
January 1995,
Journal of inflammation,
T Machleidt, and
B Krämer, and
D Adam, and
B Neumann, and
S Schütze, and
K Wiegmann, and
M Krönke
July 1995,
The Journal of biological chemistry,
T Machleidt, and
B Krämer, and
D Adam, and
B Neumann, and
S Schütze, and
K Wiegmann, and
M Krönke
October 1997,
The Journal of biological chemistry,
T Machleidt, and
B Krämer, and
D Adam, and
B Neumann, and
S Schütze, and
K Wiegmann, and
M Krönke
June 1996,
The Journal of biological chemistry,
